Vir Biotechnology (VIR) EBT Margin Growth (3y) (2021 - 2026)
Vir Biotechnology (VIR) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -43.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.26 Mn |
| Dec 31, 2025 | 23,969.00 |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | -855,061.00 |
| Mar 31, 2025 | -406,389.00 |
| Dec 31, 2024 | -91,309.00 |
| Sep 30, 2024 | -907,917.00 |
| Jun 30, 2024 | -458,603.00 |
| Mar 31, 2024 | 841,248.00 |
| Dec 31, 2023 | 601,450.00 |
| Sep 30, 2023 | -192,669.00 |
| Jun 30, 2023 | -513,284.00 |
| Mar 31, 2023 | 112,310.00 |
| Dec 31, 2022 | -797,037.00 |
| Sep 30, 2022 | 350,268.00 |
| Jun 30, 2022 | 108,127.00 |
| Mar 31, 2022 | 85,792.00 |
| Dec 31, 2021 | 72,001.00 |
| Sep 30, 2021 | 126,655.00 |